Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 116Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Recurrence 17Burkitt Lymphoma 14Lymphoma, Large B-Cell, Diffuse 8Neoplasms 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms, Plasma Cell 6Lymphoma 6Leukemia, Biphenotypic, Acute 5Immunoglobulin Light-chain Amyloidosis 5Carcinoma, Non-Small-Cell Lung 5Prostatic Neoplasms 4Lymphoma, Non-Hodgkin 4Lymphoma, B-Cell 4Waldenstrom Macroglobulinemia 3Neoplasm Metastasis 3Nausea 3Lung Neoplasms 3Leukemia 3Smoldering Multiple Myeloma 2Rectal Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Paraproteinemias 2Ovarian Neoplasms 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Leukemia, Lymphocytic, Chronic, B-Cell 2Down Syndrome 2

Interventions

Therapeutics 2Exercise 2enzalutamide 1dexamethasone acetate 1dexamethasone 21-phosphate 1darolutamide 1auricularum 1apalutamide 1Therapeutic Touch 1Testosterone 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sildenafil Citrate 1Relaxation Therapy 1Radiotherapy 1Quality of Life 1Methods 1Gels 1Exercise Test 1Electroacupuncture 1Educational Status 1Early Intervention, Educational 1Dexamethasone 1Counseling 1Consolidation Chemotherapy 1Chemoradiotherapy 1Calcium Dobesilate 1Autogenic Training 1Acupressure 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Dexamethasone × 90 days × Clear all
NCT02491632 2026-03-18

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Active not recruiting
90 enrolled 13 charts

Fatigue, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡